Related Experiment Video
Updated: Jul 14, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Delayed catastrophic antiphospholipid syndrome after massive cerebral infarction
Wei Hsi Chen1, Hung Sheng Lin, Yi Fen Kao
1Neurocritical Care Unit, Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, and School of Medicine, Chang Gung University, 123 Ta Pei Road, Niao Sung Hsiang, Kaohsiung 833, Taiwan. e49130@ms14.hinet.net
Catastrophic antiphospholipid syndrome (CAPS) can occur even with normal coagulation tests. Rapid diagnosis and treatment, including plasmapheresis, are crucial for improving outcomes in patients with this life-threatening condition.
Area of Science:
- Rheumatology
- Hematology
- Neurology
Background:
- Catastrophic antiphospholipid syndrome (CAPS) is a rare, severe systemic autoimmune disease.
- It is characterized by widespread thromboses and organ damage, requiring urgent intervention.
- Prompt diagnosis is essential for effective management and improved patient prognosis.
Observation:
- A patient with Sjogren syndrome developed CAPS, presenting with unconsciousness following cerebral ischemia.
- Initial laboratory tests, including thrombocyte count and coagulation times, were within normal limits.
- Elevated anti-beta(2)-glycoprotein I antibody levels were detected, indicating antiphospholipid antibodies.
Findings:
- The case highlights that normal hemostatic parameters do not rule out CAPS.
- Plasmapheresis was administered, leading to a rapid reversal of the patient's consciousness and coagulation function.
- High anti-beta(2)-glycoprotein I antibody levels are a key diagnostic marker for CAPS.
Implications:
- Clinicians should consider CAPS in patients with unexplained thrombotic events, even with normal coagulation profiles.
- Early recognition and aggressive treatment, such as plasmapheresis, can significantly improve outcomes in CAPS.
- This case underscores the importance of antibody testing in diagnosing antiphospholipid syndrome variants.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Cerebral Edema ll: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
